Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

被引：0
|
作者：
Marc De Hert
Johan Detraux
Ruud van Winkel
Weiping Yu
Christoph U. Correll
机构：
[1] University Psychiatric Center,Department of Psychiatry and Psychology
[2] Catholic University Leuven,undefined
[3] South Limburg Mental Health Research and Teaching Network,undefined
[4] Maastricht University Medical Center,undefined
[5]  The Zucker Hillside Hospital,undefined
[6] Psychiatry Research,undefined
来源：
Nature Reviews Endocrinology | 2012年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The contribution of antipsychotic medications to an increased risk of type 2 diabetes mellitus and cardiovascular disease is controversial. Despite existing guidelines and recommendations, many antipsychotic-drug-treated patients are not routinely assessed for metabolic and cardiac risk factors. This Review outlines the metabolic and cardiovascular risks of various antipsychotic medications in adults and children, defines the disparities in health care and makes recommendations for screening and monitoring of patients taking these agents.
引用
收藏
页码：114 / 126
页数：12
相关论文
共 50 条
  • [1] Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
    De Hert, Marc
    Detraux, Johan
    van Winkel, Ruud
    Yu, Weiping
    Correll, Christoph U.
    NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (02) : 114 - 126
  • [2] Cardiovascular Adverse Effects of Antipsychotic Drugs
    Nicholas A. Buckley
    Prashanthan Sanders
    Drug Safety, 2000, 23 : 215 - 228
  • [3] Cardiovascular adverse effects of antipsychotic drugs
    Buckley, NA
    Sanders, P
    DRUG SAFETY, 2000, 23 (03) : 215 - 228
  • [4] Cardiovascular and Metabolic Adverse Reactions Associated with the Use of Antipsychotic Drugs: A Narrative Review
    Patel, Priya C.
    Navik, Preeti L.
    Barvaliya, Manish J.
    Patel, Tejas K.
    Virani, Hemangi A.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (01) : FE01 - FE05
  • [5] Pharmacokinetic Factors in the Adverse Cardiovascular Effects of Antipsychotic Drugs
    Candace S. Brown
    Richard G. Farmer
    Judith E. Soberman
    Samantha F. Eichner
    Clinical Pharmacokinetics, 2004, 43 : 33 - 56
  • [6] Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs
    Brown, CS
    Farmer, RG
    Soberman, JE
    Eichner, SF
    CLINICAL PHARMACOKINETICS, 2004, 43 (01) : 33 - 56
  • [7] Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis
    Lambert, Tim
    AUSTRALIAN PRESCRIBER, 2011, 34 (04) : 97 - 99
  • [8] A rat model for studying metabolic adverse effects of antipsychotic drugs
    de Beaurepaire, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 31 - 31
  • [9] Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents
    McIntyre, Roger S.
    Jerrell, Jeanette M.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2008, 162 (10): : 929 - 935
  • [10] Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
    Khasawneh, Fadi T.
    Shankar, Gollapudi S.
    CARDIOLOGY RESEARCH AND PRACTICE, 2014, 2014
12345